会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • Combinatorial DNA library for producing modified N-Glycans in lower eukaryotes
    • 在Niederen Eukaryoten中的Kombinatorische DNA-Bibliothek zur Herstellung modifizierter N-Glukane
    • EP2196540A2
    • 2010-06-16
    • EP10158532.1
    • 2004-02-20
    • GlycoFi, Inc.
    • Gerngross, Tillman U.Wildt, StefanChoi, Byung-KwonNett, Juergen HermannBobrowicz, PiotrHamilton, Stephen R.Davidson, Robert C.
    • C12P21/00C12N9/10C12N9/24C12N1/14C12N5/10C12R1/645
    • C12P21/005C07K14/47C12N9/1051C12N15/1082C12N15/79
    • The present invention relates to eukaryotic host cells having modified oligosaccharides which may be modified further by heterologous expression of a set of glycosyltransferases, sugar transporters and mannosidases to become host-strains for the production of mammalian, e.g., human therapeutic glycoproteins. The invention provides nucleic acid molecules and combinatorial libraries which can be used to successfully target and express mammalian enzymatic activities such as those involved in glycosylation to intracellular compartments in a eukaryotic host cell. The process provides an engineered host cell which can be used to express and target any desirable gene(s) involved in glycosylation. Host cells with modified oligosaccharides are created or selected. N-glycans made in the engineered host cells have a Man5GlcNAc2 core structure which may then be modified further by heterologous expression of one or more enzymes, e.g., glycosyltransferases, sugar transporters and mannosidases, to yield human-like glycoproteins. For the production of therapeutic proteins, this method may be adapted to engineer cell lines in which any desired glycosylation structure may be obtained.
    • 本发明涉及具有修饰的寡糖的真核宿主细胞,其可以通过异源表达一组糖基转移酶,糖转运体和甘露糖苷酶进一步修饰,以成为用于产生哺乳动物例如人治疗性糖蛋白的宿主菌株。 本发明提供了可用于成功靶向和表达哺乳动物酶活性的核酸分子和组合文库,例如参与真核宿主细胞中细胞内区室糖基化的那些酶活性。 该方法提供了可用于表达和靶向参与糖基化的任何所需基因的工程化宿主细胞。 建立或选择具有修饰的寡糖的宿主细胞。 在工程化的宿主细胞中制备的N-聚糖具有Man5GlcNAc2核心结构,然后可以通过异源表达一种或多种酶,例如糖基转移酶,糖转运蛋白和甘露糖苷酶来进一步修饰,以产生人样糖蛋白。 为了生产治疗性蛋白质,该方法可适用于工程化可能获得任何所需糖基化结构的细胞系。
    • 8. 发明公开
    • Production of modified glycoproteins having multiple antennary structures
    • Herstellung modifizierter Glykoproteine mitmultiantennärenStrukturen
    • EP2080809A1
    • 2009-07-22
    • EP09004760.6
    • 2004-02-20
    • GlycoFi, Inc.
    • Bobrowicz, PiotrHamilton, Stephan R.Gerngross, Tillman U.Wildt, StefhanChoi, Byung-KwonNett, Juergen HermannDavidson, Robert C.
    • C12P21/00C12N9/10C12N5/10C12N15/81C12R1/84
    • C07K14/39A61K38/00C07K2319/05C12N9/1051C12P21/005Y02A50/396
    • The present invention relates to eukaryotic host cells, especially lower eukaryotic host cells, having modified oligosaccharides which may be modified further by heterologous expression of a set of glycosyltransferases, sugar and sugar nucleotide transporters to become host-strains for the production of mammalian, e.g., human therapeutic glycoproteins. The process provides an engineered host cell which can be used to express and target any desirable gene(s) involved in glycosylation. Host cells with modified lipid-linked oligosaccharides are created or selected. N-glycans made in the engineered host cells exhibit GnTIII, GnTIV, GnTV, GnT VI or GnTIX activity, which produce bisected and/or multiantennary N-glycan structures and may be modified further by heterologous expression of one or more enzymes, e.g., glycosyltransferases, sugar, sugar nucleotide transporters, to yield human-like glycoproteins. For the production of therapeutic proteins, this method may be adapted to engineer cell lines in which any desired glycosylation structure may be obtained.
    • 本发明涉及具有修饰的寡糖的真核宿主细胞,特别是低等真核宿主细胞,其可以进一步通过异源表达一组糖基转移酶,糖和糖核苷酸转运蛋白进行修饰,以成为用于产生哺乳动物的宿主菌株, 人类治疗糖蛋白。 该方法提供了可用于表达和靶向参与糖基化的任何所需基因的工程化宿主细胞。 产生或选择具有修饰的脂质连接寡糖的宿主细胞。 在工程化宿主细胞中制备的N-聚糖表现出GnTIII,GnTIV,GnTV,GnT VI或GnTIX活性,其产生二等分和/或多元N-聚糖结构,并且可以通过异源表达一种或多种酶,例如糖基转移酶 ,糖,糖核苷酸转运蛋白,以产生人样糖蛋白。 为了生产治疗性蛋白质,该方法可适用于工程化可能获得任何所需糖基化结构的细胞系。